HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  van Dijk, Janneke H ^a   Sutcliffe, Catherine G ^b   Munsanje, Bornface ^a   Sinywimaanzi, Pamela ^a   Hamangaba, Francis ^a   Thuma, Philip E ^a   Moss, William J ^b  

^a Macha Hospital   (Zambia)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; EFAVIRENZ; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS STAVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; STAVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AGE; ARTICLE; CD4+ T LYMPHOCYTE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROBABILITY; PROSPECTIVE STUDY; RURAL AREA; TIME; TRAVEL; TREATMENT OUTCOME; VIROLOGY; VIRUS LOAD; ZAMBIA; ADOLESCENT; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS; INFANT; PATHOGENICITY; PATIENT COMPLIANCE; PRESCHOOL CHILD; RURAL POPULATION;

ADOLESCENT; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HIV; HIV INFECTIONS; HUMANS; INFANT; MALE; PATIENT COMPLIANCE; RURAL POPULATION; TIME FACTORS; TREATMENT OUTCOME; ZAMBIA;

EID: 79955731747     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019006     Document Type: Article

References (40)

1. UNAIDS (2008) 2008 Report on the global AIDS epidemic Geneva, Switzerland Joint United Nations Programme on HIV/AIDS.
2. Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ, (2008) Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis 8: 477-489.
3. Ciaranello AL, Chang Y, Margulis AV, Bernstein A, Bassett IV, et al. (2009) Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis 49: 1915-1927.
4. Ojikutu B, (2007) Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation. J Infect Dis 196 (Suppl 3): S445-448.
5. van Dijk JH, Sutcliffe CG, Munsanje B, Hamangaba F, Thuma PE, et al. (2009) Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis. BMC Infect Dis 9: 169.
6. Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, et al. (2007) Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care 19: 658-665.
7. Mshana GH, Wamoyi J, Busza J, Zaba B, Changalucha J, et al. (2006) Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS 20: 649-657.
8. Posse M, Baltussen R, (2009) Barriers to access to antiretroviral treatment in Mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care STDS 23: 867-875.
9. Sutcliffe CG, van Dijk JH, Bolton-Moore C, Cotham M, Tambatamba B, et al. (2010) Differences in presentation, treatment initiation and response among children infected with human immunodeficiency virus in urban and rural Zambia. Pediatr Infect Dis J 29: 849-854.
10. Cohen R, Lynch S, Bygrave H, Eggers E, Vlahakis N, et al. (2009) Antiretroviral treatment outcomes from a nurse-driven, community-supported HIV/AIDS treatment programme in rural Lesotho: observational cohort assessment at two years. Journal of the International AIDS Society 12.
11. Janssen N, Ndirangu J, Newell ML, Bland RM, (2010) Successful paediatric HIV treatment in rural primary care in Africa. Archives of Disease in Childhood 95: 414-421.
12. Mutevedzi PC, Lessells RJ, Heller T, Barnighausen T, Cooke SG, et al. (2010) Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull World Health Organ 88: 593-600.
13. Shumbusho F, van Griensven J, Lowrance D, Turate I, Weaver MA, et al. (2009) Task shifting for scale-up of HIV care: evaluation of nurse-centered antiretroviral treatment at rural health centers in Rwanda. PLoS Medicine/Public Library of Science 6: e1000163.
14. Bedelu M, Ford N, Hilderbrand K, Reuter H, (2007) Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis 196 (Suppl 3): S464-468.
15. Fredlund VG, Nash J, (2007) How far should they walk? Increasing antiretroviral therapy access in a rural community in northern KwaZulu-Natal, South Africa. J Infect Dis 196 (Suppl 3): S469-473.
16. Barth RE, van der Meer JT, Hoepelman AI, Schrooders PA, van de Vijver DA, et al. (2008) Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa. European Journal of Clinical Microbiology & Infectious Diseases 27: 977-984.
17. Jaffar S, Amuron B, Foster S, Birungi J, Levin J, et al. (2009) Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet 374: 2080-2089.
18. Kipp W, Konde-Lule J, Saunders LD, Alibhai A, Houston S, et al. (2010) Results of a community-based antiretroviral treatment program for HIV-1 infection in Western Uganda. Curr HIV Res 8: 179-185.
19. Carlucci JG, Kamanga A, Sheneberger R, Shepherd BE, Jenkins CA, et al. (2008) Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr 47: 615-622.
20. WHO (2006) Antiretroviral therapy of HIV infection in infants and children: Towards universal access. Recommendations for a public health approach Geneva, Switzerland World Health Organization.
21. WHO (2008) Report of the WHO Technical Reference Group, Paediatric HIV/ART Care Guideline Group Meeting Geneva, Switzerland World Health Organization.
22. Central Statistical Office (2002) Demographic and Health Survey Zambia Final Report 2001/02.
23. WHO (2007) The WHO Child Growth Standards. Available at: http://www.who.int/childgrowth/en/.
24. WHO (2001) Iron deficiency anaemia: assessment, prevention and control. A guide for program managers Geneva, Switzerland World Health Organization.
25. Sutcliffe CG, Bolton-Moore C, van Dijk JH, Cotham M, Tambatamba B, et al. (2010) Secular trends in pediatric antiretroviral treatment programs in rural and urban Zambia: a retrospective cohort study. BMC Pediatr 10: 54.
26. The KIDS-ART-LINC Collaboration (2008) Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. J Acquir Immune Defic Syndr 49: 523-531.
27. Davies MA, Keiser O, Technau K, Eley B, Rabie H, et al. (2009) Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. S Afr Med J 99: 730-737.
28. Fenner L, Brinkhof MW, Keiser O, Weigel R, Cornell M, et al. (2010) Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J Acquir Immune Defic Syndr 54: 524-532.
29. Brinkhof MW, Pujades-Rodriguez M, Egger M, (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 4: e5790.
30. Barth RE, van der Meer JT, Hoepelman AI, Schrooders PA, van de Vijver DA, et al. (2008) Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa. Eur J Clin Microbiol Infect Dis 27: 977-984.
31. Starr SE, Fletcher CV, Spector SA, Yong FH, Fenton T, et al. (1999) Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team. N Engl J Med 341: 1874-1881.
32. van Leth F, Phanuphak P, Ruxrungtham K, Baraldi E, Miller S, et al. (2004) Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. Lancet 363: 1253-1263.
33. Puthanakit T, Oberdorfer A, Akarathum N, Kanjanavanit S, Wannarit P, et al. (2005) Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program. Clin Infect Dis 41: 100-107.
34. Kamya MR, Mayanja-Kizza H, Kambugu A, Bakeera-Kitaka S, Semitala F, et al. (2007) Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr 46: 187-193.
35. Emmett SD, Cunningham CK, Mmbaga BT, Kinabo GD, Schimana W, et al. (2010) Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study. J Acquir Immune Defic Syndr 54: 368-375.
36. Rongkavilit C, Naar-King S, Chuenyam T, Wang B, Wright K, et al. (2007) Health risk behaviors among HIV-infected youth in Bangkok, Thailand. J Adolesc Health 40: 358 e351-358.
37. Nyandiko WM, Ayaya S, Nabakwe E, Tenge C, Sidle JE, et al. (2006) Outcomes of HIV-Infected orphaned and non-orphaned children on antiretroviral therapy in Western Kenya. J Acquir Immune Defic Syndr 43: 418-425.
38. Wamalwa DC, Farquhar C, Obimbo EM, Selig S, Mbori-Ngacha DA, et al. (2007) Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children. J Acquir Immune Defic Syndr 45: 311-317.
39. Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM, (2008) A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J 27: 686-691.
40. Gusdal AK, Obua C, Andualem T, Wahlstrom R, Tomson G, et al. (2009) Voices on adherence to ART in Ethiopia and Uganda: a matter of choice or simply not an option? AIDS Care 21: 1381-1387.